New Risk • Jul 28
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings are forecast to decline by an average of 148% per year for the foreseeable future. High level of non-cash earnings (129% accrual ratio). Shareholders have been substantially diluted in the past year (over 9x increase in shares outstanding). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (US$68.5m market cap). Announcement • Jul 28
Enlivex Ltd. announced that it expects to receive $400 million in funding Enlivex Ltd. announced that it has entered into a securities purchase agreement with a single institutional investor with respect to the private placement to issue 80,000,000 shares at an issue price of $5 per share for gross proceeds of $400,000,000 on July 28, 2026. The securities purchase agreement also provides the Company with the right, but not the obligation, exercisable in its sole discretion at any time and from time to time during the 36-month period following the closing of the Transaction, to require the investor in the Transaction to purchase up to an additional $400,000,000 of ordinary shares (or ordinary share equivalents in lieu thereof) on the same pricing terms described above. The Company has no obligation to exercise this right, and the investor has no right to require the Company to do so. The closing of the Transaction is subject to approval by the Company’s shareholders of the issuance of the securities and the ordinary shares issuable pursuant to the Company’s put right described above for purposes of Nasdaq Listing Rules 5635(a) and 5635(b) and Section 274 of the Israeli Companies Law. The Company expects to consummate the Transaction promptly following receipt of such shareholder approval. New Risk • Jul 15
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: US$97.2m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings are forecast to decline by an average of 148% per year for the foreseeable future. High level of non-cash earnings (129% accrual ratio). Shareholders have been substantially diluted in the past year (over 9x increase in shares outstanding). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (US$97.2m market cap). 
